J
Jean-Paul Degaute
Researcher at Université libre de Bruxelles
Publications - 94
Citations - 4089
Jean-Paul Degaute is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 34, co-authored 93 publications receiving 3911 citations.
Papers
More filters
Journal ArticleDOI
Serial lactate determinations during circulatory shock.
Jean Louis Vincent,Philippe Dufaye,Jacques Berré,Marc Leeman,Jean-Paul Degaute,Robert J. Kahn +5 more
TL;DR: During circulatory shock, repeated lactate determinations represent a more reliable prognostic index than an initial value taken alone and changes in lactate concentration can provide an early and objective evaluation of the patient's response to therapy.
Journal ArticleDOI
Quantitative analysis of the 24-hour blood pressure and heart rate patterns in young men.
TL;DR: Modulatory factors different from those controlling nycterohemeral changes in blood pressure influence the 24-hour variation in heart rate, which may reflect an endogenous circadian rhythm, amplified by the effect of sleep.
Journal ArticleDOI
Effects of wake and sleep stages on the 24-h autonomic control of blood pressure and heart rate in recumbent men.
TL;DR: A clear 24-h variation in sympathetic and vagal tone but not in arterial BRS persists, independent of changes in activity and position.
Journal ArticleDOI
A study of the dynamic interactions between sleep EEG and heart rate variability in healthy young men.
Fabrice Jurysta,P. van de Borne,Pierre-François Migeotte,Martine Dumont,Jean Pol Lanquart,Jean-Paul Degaute,Paul Linkowski +6 more
TL;DR: All electroencephalographic power bands are linked to normalized high frequency and modifications in cardiac vagal activity show predominantly parallel changes and precede changes in delta band by a phase shift corresponding to a lead of 12+/-5 min.
Journal ArticleDOI
Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
Philippe Gosse,Desmond John Sheridan,Faiez Zannad,Olivier Dubourg,P. Guéret,Yuri Karpov,Peter W. de Leeuw,Jose-Luis Palma-Gamiz,Achille C. Pessina,Wolfgang Motz,Jean-Paul Degaute,Claude Chastang +11 more
TL;DR: Indapamide SR 1.5 mg was significantly more effective than enalapril 20 mg at reducing LVMI in hypertensive patients with LVH, and progressively reduced wall thicknesses throughout the 1-year treatment period.